|
|
||||||||
BRIEF REVIEWS |
Department of Immunology and Parasitology, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto, Tokushima, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
When naive CD4+ T cells recognize peptides on MHC, they proliferate and differentiate into Th1 or Th2 effector cells (10). Th1 cells secrete IFN-
and play major roles in resistance to intracellular pathogens, including Leishmania major, Toxoplasma gondii, and Mycobacterium tuberculosis. Th2 cells secrete IL-4 and enhance humoral immunity that takes part in protection from extracellular pathogens. The balance of CD4+ T cell differentiation toward Th1 and Th2 is a critical determinant in some infections or autoimmune diseases (9, 10). In addition to Th1 and Th2 differentiation, naive CD4+ T cells can differentiate into regulatory T cells (Treg)2 by Ag recognition (11, 12). Treg have roles in preventing autoimmunity and inflammation by excessive immune responses (13). Regarding CD8+ T cells, naive CD8+ T cells differentiate into effector T cells with cytotoxic functions and/or IFN-
secretion after Ag stimulation. A recent article has revealed that a transcriptional factor, Eomesodermin, is one of the factors that regulates CD8+ T cell effector functions (14), but the direct target genes of this transcriptional factor remain unclear.
Although there are many articles addressing the molecules that regulate effector functions or activation of CD4+ and CD8+ T cells (10, 15, 16), the entire cellular and molecular mechanisms governing the effector functions in mature T cells have not been revealed. We and other groups have recently demonstrated that mature T cells express Notch molecules, known as a cell fate regulator, and Notch signaling regulates mature T cell activation and differentiation (17, 18, 19), although there are discrepancies among the different experimental systems. Since previous articles have revealed the involvement of Notch signaling in the lineage decision toward T cells from lymphoid progenitors (20), Notch signaling appears to govern many key aspects of immature as well as mature T cell development. Regarding the role of Notch signaling in T cell development in the thymus, there are several good reviews elsewhere (20, 21, 22, 23). Thus, in this study we review the role of Notch signaling, focusing on mature T cell differentiation and activation.
| Notch signaling |
|---|
|
|
|---|
-secretase and Notch-IC translocates to the nucleus (23, 24) (Fig. 1). In the nucleus, Notch-IC binds to RBP-J
(also known as CBF-1 and CSL in mammals) and converts it from a transcriptional repressor to an activator (23) (Fig. 1). Several target genes of Notch, including Hes1, Hes5, and pT
(25, 26), have been identified, but the essential target genes in each biological event are largely unknown.
|
| Notch and T cell development |
|---|
|
|
|---|
Notch1 was also reported to modulate the
selection step of thymocytes (26). Reizis and Leder (26) revealed that the enhancer region of pT
has a binding site for Notch and indeed, mutation of the binding sites abolished enhancer induction by Notch. This is supported by the finding that conditional inactivation of Notch1 by Lck-Cre leads to the accumulation of CD4CD8CD25+CD44 cells, which is also observed in pT
- and RAG1-deficient mice (30).
There are a number of articles suggesting that 
/
and CD4/CD8 T cell fate decisions are modulated by Notch signaling (23, 31, 32). There are discrepancies among these reports about those issues, which may be explained by the mixed contribution of four types of Notch molecules or redundancy of signaling among Notch molecules in either step. Thus, it will be important to address the role of Notch signaling in terms of 
/
and CD4/CD8 T cell fate decisions by crossing each Notch-deficient mice or down-regulating several Notch molecules in T cells by the RNA interference technique.
| Notch-related gene expression in the peripheral immune system |
|---|
|
|
|---|
| Effect of Notch on Th1/Th2/Treg differentiation |
|---|
|
|
|---|
production of Ag-stimulated T cells. They also showed that stimulation by Jagged1 or the overexpression of Notch1-IC increased IL-4 production, suggesting that the Jagged1-Notch1 pathway directed Th2 cell differentiation (19). However, this study did not prove the Th2 regulation by a direct interaction between Jagged1 and Notch1. In addition, RBP-J
-deficient mice showed a drastic reduction in serum concentrations of IgG1 and IgE, suggesting biased Th1-immune responses in the absence of one of the major target molecules of Notch, RBP-J
(38). Although it should be addressed how Notch signaling is associated with many known Th1- or Th2-inducing factors, including cytokines or transcriptional factors (9, 10, 16), the discovery of the contribution of Notch signaling in Th1/Th2 differentiation would open a new pathway about the regulation of helper T cell differentiation. Furthermore, it should be addressed whether the mode of Notch signaling induced by each Notch ligand is different in terms of helper T cell differentiation. In contrast, several articles suggest that Jagged1 induces Ag-specific Treg instead of Th2 (34, 39, 40). Hoyne et al. (34) found that injection of Jagged1-transfected DCs into mice induced Treg, although this study does not prove the direct contribution of Jagged1 to the differentiation of naive CD4+ T cells to Treg. Brenners group (39, 40) found that the stimulation of human CD4+ T cells by Jagged1 allowed induction of Treg. Since the differentiation of Th2 by the stimulation of T cells by Jagged1 was observed in mice (19), the role of Jagged1 in terms of CD4+ T cell differentiation may be different between mice and humans.
| Effect of Notch on T cell proliferation |
|---|
|
|
|---|
-secretase inhibitors, which were the inhibitors of Notch signaling, dramatically decreased T cell proliferation (33, 41). In addition, Adler et al. (33) reported that overexpression of Notch1-IC enhanced CD4+ T cell proliferation and CD4+ T cell proliferation was reduced in RBP-J
-deficient mice (38), suggesting that the activation of the Notch pathway enhanced T cell proliferation.
|
production at a low dose without any growth suppression (17). Furthermore, most of the experiments that observed a T cell suppressive effect by Notch signaling used overexpressed ligands on APCs (18, 34, 39, 40). In contrast, the experiments which found an enhanced effect of Notch on T cell proliferation did not use the overexpressed ligands. Thus, high concentrations of ligands might decrease T cell proliferation, whereas a low dose increases or does not affect the proliferation dependent on Notch ligands. In the future, it should be addressed whether different types of Notch ligands induce quantitative or qualitative distinct signals in terms of T cell proliferation.
The second hypothesis is that APCs might express factors, which affect T cell responsiveness, by modulating Notch signaling. Eagar et al. (18) indicated that the inhibitor of
-secretase enhanced CD4+ T cell proliferation, whereas other groups revealed the opposite results (33, 41). The major difference in conditions of these two experiments is that the former used purified CD4+ T cells, whereas the latter used total lymph node cells or spleen cells. Indeed, Eagar et al. (18) reported that the inhibitor did not affect the proliferation in the presence of APCs. In addition, Tanigaki et al. (38) reported that RBP-J
-deficient T cells showed reduced proliferation in the presence of APCs, but not in the absence of APCs (38). Those results suggested that Notch signaling overcomes some inhibitory effects of APCs against T cell activation.
Although we do not have direct answers whether APCs or the dose of Notch ligands contributes to the controversial results, the examination about the precise expression pattern of Notch and Notch ligands or the pairing pattern of Notch and Notch ligands during immune responses would help to solve these issues. Furthermore, it would be essential to examine these issues using in vivo experimental systems to fully understand the precise role of Notch signaling in CD4+ T cell responses.
| Effect of Notch on CD8+ T cells |
|---|
|
|
|---|
secretion with a concomitant enhancement of IL-10 production (42). Vigouroux et al. (39) indicated that cytotoxic functions of CD8+ T cells were suppressed by stimulation of Jagged1. These results indicate that the activation of Notch suppressed CD8+ T cell effector functions. On the contrary, Palaga et al. (41) reported that the number of IFN-
-producing CD8+ T cells was significantly reduced by Notch1 antisense and
-secretase inhibitor (IL-CHO), indicating that the activation of Notch is required for CD8+ T cell function. This discrepancy might be also explained by the effects of APCs on Notch signaling similar to that in CD4+ T cells because the experiments indicating the suppressive effect used overexpressed ligands and those indicating enhancement, which is seen in CD4+ T cells, used total lymph nodes. | Intracellular signaling in T cells induced by Notch |
|---|
|
|
|---|
Amsen et al. (19) found three RBP-J
sites in the 3' enhancer region of the IL-4 gene. They used transgenic mice in which a luciferase reporter is controlled by IL-4 transcriptional regulatory elements, including the 3' enhancer region. Overexpression of Notch1-IC in T cells from these mice induced luciferase activity that is highly dependent on the RBP-J
sites in the 3' enhancer. These results indicate that the IL-4 gene is a direct target of Notch signaling, and this pathway may contribute to Th2 differentiation.
The NF-
B family of transcription factors is involved in various immune responses. In mammals, five members have been identified: c-Rel, RelA (p65), RelB, NF-
B1 (p50/p105), and NF-
B2 (p52/p100). With regard to peripheral T cell differentiation, the mice lacking NF-
B1 failed to induce GATA3 expression in CD4+ T cells and were unable to induce Th2 differentiation (43), whereas mice lacking c-Rel were defective in the Th1 response (44). In addition, several reports indicated that Notch influences NF-
B activation. For instance, Palaga et al. (41) indicated that
-secretase inhibitor IL-CHO and Notch1 antisense inhibited NF-
B activation in CD4+ T cells stimulated by anti-CD3/CD28 or Con A. Oswald et al. (45) revealed that transcription of NF-
B2 was suppressed by RBP-J
and activated by overexpression of Notch1-IC in Jurkat T cells. It remains unclear how these effects of Notch on NF-
B influence T cell differentiation. It would be necessary to address whether different Notch molecules or different pairs of Notch and Notch ligands have distinct regulation of NF-
B members.
The signal CD28 leads to the activation of the PI3K/AKT pathway (46, 47). This pathway has an important role in T cell activation and/or cytokine production (48, 49). Sade et al. (50) revealed that Notch1-IC formed a complex with p56lck and PI3K in Jurkat and primary T cells of mice and activated the PI3K/AKT signaling pathway in Jurkat and 2B4 mouse T cell hybridomas. In contrast, Eagar et al. (18) indicated that Notch1 activation inhibited AKT and its downstream effector GSK-3
phosphorylation in naive CD4+ T cells of mice, but did not affect ERK1/2 phosphorylation. The types of cells or the culture conditions might cause these conflicting results. Additional experiments should be performed to examine whether the PI3K/AKT pathway has any role in the effects of Notch on peripheral T cells.
Recently, Kamakura et al. (51) indicated that active Notch1 could induce STAT3 activation through Hes1 and Hes5, which are the target genes of Notch. They also revealed that Hes1 and Hes5 formed a complex with JAK2 and STAT3, thereby promoting STAT3 phosphorylation and activation (51). Although Amsen et al. (19) revealed that Notch-induced IL-4 production independent of STAT6, it would be interesting to examine whether other STATs could be activated by Notch and involved in peripheral T cell differentiation.
| Conclusion |
|---|
|
|
|---|
In mammals, there are four Notch molecules and at least five Notch ligands (24). Those receptors and ligands can interact with each other (52, 53) and the expression pattern of each molecule is not restricted (37), which makes it difficult to analyze the role of Notch systems in mature T cell differentiation/activation. Furthermore, Notch molecules are glycosylated by several glycosyltransferases, which is critical for appropriate interactions with the Notch ligands (54, 55, 56, 57, 58). The complex pattern of regulation of Notch by glycosylation rather than just expression of Notch molecules may determine the effects of cell-specific Notch signaling. Thus, in the future, the establishment of mAbs, gene-targeted mice of Notch-related molecules, or the detailed role of glycosylation of Notch receptors would facilitate the research of Notch and reveal the physiological roles of Notch signaling in mature T cell differentiation and activation.
Since the first article showing the role of Notch1 on CD4/CD8 T cell fate choice was published in 1996 (31), many articles have revealed the essential roles of Notch1 in T cell development in the thymus. In the past 2 years, we and other groups have revealed the contribution of Notch signaling in mature T cell differentiation/activation. These results suggest that Notch signaling is responsible for many key aspects during the life of T cells. Considering the broad roles of Notch signaling in many types of cell differentiation or lineage commitment, it is interesting to assess whether Notch signaling in T cells has specific target genes or whether Notch signaling affects similar gene expression independent of the cell type, and other factors specifically expressed in each cell determine the outcome of the cell activation and differentiation.
Although we have yet to reveal the detailed regulatory systems of Notch signaling in terms of mature T cell differentiation/activation, it would be interesting to determine whether defective Notch signaling is responsible for the pathogenesis of autoimmune diseases. Furthermore, Notch-related molecules might be targets for therapeutic strategies against autoimmune disease or tumors.
| Footnotes |
|---|
1 Address correspondence and reprint requests to Dr. Koji Yasutomo, Department of Immunology and Parasitology, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15 Kuramoto, Tokushima 770-8503, Japan. E-mail address: yasutomo{at}basic.med.tokushima-u.ac.jp ![]()
2 Abbreviations used in this paper: Treg, regulatory T cell; IC, intracellular domain; DC, dendritic cell. ![]()
Received for publication July 28, 2004. Accepted for publication September 30, 2004.
| References |
|---|
|
|
|---|
rearrangement and allows pre-TCR-independent survival of early
Lineage Thymocytes. Immunity 16:869.[Medline]
versus 
T cell lineage decision. Cell 88:833.[Medline]
1 in antigen presenting cells in mice. Immunol. Lett. 81:59.[Medline]
/
T cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling. Immunity 20:611.[Medline]
production in peripheral T cells. J. Immunol. 171:3019.
1 inhibits peripheral immune responses to transplantation antigens by a CD8+ cell-dependent mechanism. J. Clin. Invest. 112:1741.[Medline]
B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45.[Medline]
B2 is a putative target gene of activated Notch-1 via RBP-J
. Mol. Cell. Biol. 18:2077.
but not TH2 cytokines. Nat. Immunol. 2:37.[Medline]
1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem. Biophys. Res. Commun. 276:385.[Medline]
This article has been cited by other articles:
![]() |
A. L. Radke, L. E. Reynolds, R. C. N. Melo, A. M. Dvorak, P. F. Weller, and L. A. Spencer Mature human eosinophils express functional Notch ligands mediating eosinophil autocrine regulation Blood, March 26, 2009; 113(13): 3092 - 3101. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kijima, A. Iwata, Y. Maekawa, H. Uehara, K. Izumi, A. Kitamura, H. Yagita, S. Chiba, H. Shiota, and K. Yasutomo Jagged1 Suppresses Collagen-Induced Arthritis by Indirectly Providing a Negative Signal in CD8+ T Cells J. Immunol., March 15, 2009; 182(6): 3566 - 3572. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sakata-Yanagimoto, E. Nakagami-Yamaguchi, T. Saito, K. Kumano, K. Yasutomo, S. Ogawa, M. Kurokawa, and S. Chiba From the Cover: Coordinated regulation of transcription factors through Notch2 is an important mediator of mast cell fate PNAS, June 3, 2008; 105(22): 7839 - 7844. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kijima, T. Yamaguchi, C. Ishifune, Y. Maekawa, A. Koyanagi, H. Yagita, S. Chiba, K. Kishihara, M. Shimada, and K. Yasutomo Dendritic cell-mediated NK cell activation is controlled by Jagged2-Notch interaction PNAS, May 13, 2008; 105(19): 7010 - 7015. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, C. J. Krawczyk, and E. J. Pearce Suppression of Th2 Cell Development by Notch Ligands Delta1 and Delta4 J. Immunol., February 1, 2008; 180(3): 1655 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Elyaman, E. M. Bradshaw, Y. Wang, M. Oukka, P. Kivisakk, S. Chiba, H. Yagita, and S. J. Khoury Jagged1 and Delta1 Differentially Regulate the Outcome of Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 2007; 179(9): 5990 - 5998. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Rubio-Aliaga, D. Soewarto, S. Wagner, M. Klaften, H. Fuchs, S. Kalaydjiev, D. H. Busch, M. Klempt, B. Rathkolb, E. Wolf, et al. A Genetic Screen for Modifiers of the Delta1-Dependent Notch Signaling Function in the Mouse Genetics, March 1, 2007; 175(3): 1451 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Matesic, D. C. Haines, N. G. Copeland, and N. A. Jenkins Itch genetically interacts with Notch1 in a mouse autoimmune disease model Hum. Mol. Genet., December 15, 2006; 15(24): 3485 - 3497. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Tsukumo, K. Hirose, Y. Maekawa, K. Kishihara, and K. Yasutomo Lunatic Fringe Controls T Cell Differentiation through Modulating Notch Signaling J. Immunol., December 15, 2006; 177(12): 8365 - 8371. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |